Cargando…

Prevalence and impact of myocardial injury among patients hospitalized with COVID-19

BACKGROUND: Myocardial injury is a prevalent complication observed in patients hospitalized with COVID-19 and is strongly associated with severe illness and in-hospital mortality. However, the long-term consequences of myocardial injury on clinical outcomes remain poorly understood. This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Vu Hoang, Nguyen, Thanh Cong, Pham, Quang Dang Duy, Pham, Dan Ngoc, Le, Le Bao, Le, Khoi Minh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433191/
https://www.ncbi.nlm.nih.gov/pubmed/37600048
http://dx.doi.org/10.3389/fcvm.2023.1202332
_version_ 1785091594989338624
author Vu, Vu Hoang
Nguyen, Thanh Cong
Pham, Quang Dang Duy
Pham, Dan Ngoc
Le, Le Bao
Le, Khoi Minh
author_facet Vu, Vu Hoang
Nguyen, Thanh Cong
Pham, Quang Dang Duy
Pham, Dan Ngoc
Le, Le Bao
Le, Khoi Minh
author_sort Vu, Vu Hoang
collection PubMed
description BACKGROUND: Myocardial injury is a prevalent complication observed in patients hospitalized with COVID-19 and is strongly associated with severe illness and in-hospital mortality. However, the long-term consequences of myocardial injury on clinical outcomes remain poorly understood. This study aimed to assess the impact of myocardial injury on both acute-phase and long-term prognosis in COVID-19 patients. METHODS: A retrospective, observational study was conducted on all patients who received treatment at the Intensive Care Center for COVID-19 patient, University Medical Center Ho Chi Minh City (UCICC), from August 3rd, 2021, to October 28th, 2021. RESULTS: A total of 582 patients were enrolled in the study, of which 55.3% were female. The mean age of participants was 63.3 ± 16.2. Out of these patients, 330 cases (56.8%) showed myocardial injury. Compared to patients without myocardial injury, those with myocardial injury were older and had a higher incidence of chronic diseases including hypertension, ischemic heart disease, atrial fibrillation, heart failure, diabetes mellitus, chronic kidney disease. They also presented with more severe respiratory failure upon admission and showed a more pronounced abnormality in inflammation and kidney function tests. Furthermore, the in-hospital mortality rate was significantly higher in the group with myocardial injury (49.7% vs 14.3%, p < 0.001). After adjusting for age, gender, comorbidities, renal function, and disease severity at admission, myocardial injury emerged as an independent risk factor for in-hospital mortality (OR = 3.758, 95% CI 1.854–7.678, p < 0.001). Among successfully discharged COVID-19 patients, the all-cause mortality rate after a median follow-up of 18.4 months was 7.9%. Patients with myocardial injury had a significantly higher long-term mortality rate compared to those without myocardial injury (14.0% vs. 3.2%, p < 0.001). However, multivariable Cox regression analysis did not find myocardial injury to be a significant predictor of long-term mortality (HR = 2.128, 95% CI 0.792–5.712, p = 0.134). CONCLUSIONS: Myocardial injury is a common and serious complication in hospitalized COVID-19 patients, associated with increased in-hospital mortality. However, it does not significantly impact long-term mortality in successfully discharged COVID-19 patients.
format Online
Article
Text
id pubmed-10433191
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104331912023-08-18 Prevalence and impact of myocardial injury among patients hospitalized with COVID-19 Vu, Vu Hoang Nguyen, Thanh Cong Pham, Quang Dang Duy Pham, Dan Ngoc Le, Le Bao Le, Khoi Minh Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Myocardial injury is a prevalent complication observed in patients hospitalized with COVID-19 and is strongly associated with severe illness and in-hospital mortality. However, the long-term consequences of myocardial injury on clinical outcomes remain poorly understood. This study aimed to assess the impact of myocardial injury on both acute-phase and long-term prognosis in COVID-19 patients. METHODS: A retrospective, observational study was conducted on all patients who received treatment at the Intensive Care Center for COVID-19 patient, University Medical Center Ho Chi Minh City (UCICC), from August 3rd, 2021, to October 28th, 2021. RESULTS: A total of 582 patients were enrolled in the study, of which 55.3% were female. The mean age of participants was 63.3 ± 16.2. Out of these patients, 330 cases (56.8%) showed myocardial injury. Compared to patients without myocardial injury, those with myocardial injury were older and had a higher incidence of chronic diseases including hypertension, ischemic heart disease, atrial fibrillation, heart failure, diabetes mellitus, chronic kidney disease. They also presented with more severe respiratory failure upon admission and showed a more pronounced abnormality in inflammation and kidney function tests. Furthermore, the in-hospital mortality rate was significantly higher in the group with myocardial injury (49.7% vs 14.3%, p < 0.001). After adjusting for age, gender, comorbidities, renal function, and disease severity at admission, myocardial injury emerged as an independent risk factor for in-hospital mortality (OR = 3.758, 95% CI 1.854–7.678, p < 0.001). Among successfully discharged COVID-19 patients, the all-cause mortality rate after a median follow-up of 18.4 months was 7.9%. Patients with myocardial injury had a significantly higher long-term mortality rate compared to those without myocardial injury (14.0% vs. 3.2%, p < 0.001). However, multivariable Cox regression analysis did not find myocardial injury to be a significant predictor of long-term mortality (HR = 2.128, 95% CI 0.792–5.712, p = 0.134). CONCLUSIONS: Myocardial injury is a common and serious complication in hospitalized COVID-19 patients, associated with increased in-hospital mortality. However, it does not significantly impact long-term mortality in successfully discharged COVID-19 patients. Frontiers Media S.A. 2023-08-01 /pmc/articles/PMC10433191/ /pubmed/37600048 http://dx.doi.org/10.3389/fcvm.2023.1202332 Text en © 2023 Vu, Nguyen, Pham, Pham, Le and Le. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Vu, Vu Hoang
Nguyen, Thanh Cong
Pham, Quang Dang Duy
Pham, Dan Ngoc
Le, Le Bao
Le, Khoi Minh
Prevalence and impact of myocardial injury among patients hospitalized with COVID-19
title Prevalence and impact of myocardial injury among patients hospitalized with COVID-19
title_full Prevalence and impact of myocardial injury among patients hospitalized with COVID-19
title_fullStr Prevalence and impact of myocardial injury among patients hospitalized with COVID-19
title_full_unstemmed Prevalence and impact of myocardial injury among patients hospitalized with COVID-19
title_short Prevalence and impact of myocardial injury among patients hospitalized with COVID-19
title_sort prevalence and impact of myocardial injury among patients hospitalized with covid-19
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433191/
https://www.ncbi.nlm.nih.gov/pubmed/37600048
http://dx.doi.org/10.3389/fcvm.2023.1202332
work_keys_str_mv AT vuvuhoang prevalenceandimpactofmyocardialinjuryamongpatientshospitalizedwithcovid19
AT nguyenthanhcong prevalenceandimpactofmyocardialinjuryamongpatientshospitalizedwithcovid19
AT phamquangdangduy prevalenceandimpactofmyocardialinjuryamongpatientshospitalizedwithcovid19
AT phamdanngoc prevalenceandimpactofmyocardialinjuryamongpatientshospitalizedwithcovid19
AT lelebao prevalenceandimpactofmyocardialinjuryamongpatientshospitalizedwithcovid19
AT lekhoiminh prevalenceandimpactofmyocardialinjuryamongpatientshospitalizedwithcovid19